Delivery Order SPE2DB22D1202-SPE2DB25FVMF6
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 60 tablets of Corlanor 5 mg, valued at $3,636.97. The award, made on August 26, 2025, represents a firm fixed price delivery order with an ultimate completion date of August 27, 2025. This delivery order operates under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Corlanor 5 mg tablets (60-count packaging) with a ceiling value of $1,399.38. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and is scheduled for ultimate completion by August 5, 2025. The contract will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $2,199.18 to AmerisourceBergen Drug Corp for Corlanor 5 mg tablets (60-count) on September 12, 2025, with an ultimate completion date of September 15, 2025. This firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's facility in Conshohocken, Pennsylvania. The award represents a competitive procurement under AmerisourceBergen's existing federal contract portfolio with DLA. This...
- The U.S. Defense Logistics Agency's Medical Supply Chain issued a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Corlanor 5mg (60 tablets), a cardiovascular medication used to treat heart failure. This firm fixed-price delivery order, valued at $14,857.42, represents a competitively awarded non-set-aside contract with an ultimate completion date of October 6, 2025. The work will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Corlanor 5 mg tablets (60-count unit) valued at $4,410.48 under a firm fixed-price contract type. This award represents a competitively awarded, non-set-aside delivery order with an ultimate completion date of September 15, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major...
- The Defense Logistics Agency awarded a $10,382.17 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Corlanor 5 mg, a cardiovascular medication used to treat heart failure. This firm fixed-price contract, awarded on June 2, 2025, with an ultimate completion date of June 3, 2025, represents a direct purchase from the vendor's existing Indefinite Delivery Contract with DLA. The award involved no set-aside designation and was competitively awarded. Performance will occur at...
- The Defense Logistics Agency awarded a delivery order valued at $4,615.05 to AmerisourceBergen Drug Corp for Corlanor 7.5 mg tablets (60-count units) on August 5, 2025, with completion expected by August 6, 2025. This competitively awarded, firm fixed-price contract represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to AmerisourceBergen's facility in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,642.24 to AmerisourceBergen Drug Corp for the supply of Corlanor 5 mg tablets (60-count) on July 21, 2025, with an ultimate completion date of July 22, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania location. The contract represents a routine pharmaceutical procurement supporting federal medical supply needs...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Corlanor 5 mg tablets (60-count) valued at $2,313.94. This firm fixed-price, competitively awarded delivery order is scheduled for completion by September 19, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was applied to this award. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite...
- The Defense Logistics Agency awarded a $30.4K delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Corlanor 5 mg tablets (60-count units). This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of September 29, 2025, and performance to be executed from the contractor's facility in Conshohocken, Pennsylvania. The award represents a direct purchase under AmerisourceBergen's broader pharmaceutical supply relationship with the...
- SPE2DB22D1202Indefinite Delivery Contract
- SPE2DB22D1202-SPE2DB25FVMF6Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,555.55 on September 24, 2025, for the supply of Corlanor 5 mg tablets (60-count units). This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The order is scheduled for completion by September 25, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (contract SPE2DX), a comprehensive global pharmaceutical supply vehicle valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen supplies a broad range of medications and medical supplies to support military and veteran healthcare systems. The Corlanor tablets being procured are used to treat heart failure, representing the type of specialized pharmaceutical commodity that AmerisourceBergen routinely delivers through its federal contracts.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 9/24/25 |